Protedyne Corporation
Protedyne is a Complete Solutions Provider to biotech and pharmaceutical companies engaged in genome-based drug discovery research such as:
|
|
Protedyne combines unparalleled experience in cutting edge factory automation and software development with a deep scientific knowledge of genomic research. This combination of hardware, software and understanding of the scientific process allows Protedyne to transcend the limitations of traditional equipment providers and contract research labs. Through a Complete Solutions strategy, Protedyne offers custom equipment and/or contract research to maximize research capability and efficiency.
Protedyne analyzes the total R&D effort of a customer and rapidly develops a solution to meet these needs. The result is a new concept called Protocols For Automation™ (PFA™). Protedyne's PFA process enables customers to overcome bottlenecks that cannot be solved with competitors' off-the-shelf equipment. Frequently, experimental bottlenecks and low throughput challenges are direct consequences of forcing experimental processes onto readily available, off-the-shelf automation products. At Protedyne, we customize robotic platforms to specifically and optimally serve the experimental processes for which they are designed.
Protedyne's Complete Solutions strategy involves custom equipment, contract research, or a blend of both. For large-scale production customers, the PFA may recommend Protedyne's customized equipment – our BioCube Systems™. Protedyne's BioCubes are true industrial grade automation platforms, specifically designed to ensure robust and dependable operation. For clients who do not maintain high throughput labs or who wish to accelerate their research through outsourcing, the PFA may recommend contract services through our BioResearch Team. This team uses the BioCube Systems in our fully equipped 2,000 sq ft laboratory.
The Protedyne team captures expertise from several arenas, using knowledge and flexibility to envision a Complete Solution to satisfy any experimental challenge.